Navigation Links
Laureate Pharma Announces Signing New Biopharmaceutical Development & Manufacturing Agreement
Date:10/21/2009

PRINCETON, N.J., Oct. 21 /PRNewswire/ -- Laureate Pharma, Inc., a full-service biopharmaceutical development and protein production company, today announced that it has signed a new Biopharmaceutical Development and Manufacturing Agreement with an undisclosed client. According to the agreement, Laureate will develop the process to manufacture a unique Fc Fusion Protein and produce this product under cGMP conditions for use in clinical trials. Terms of the manufacturing agreement were not disclosed.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080131/NETH020LOGO )

"This project is a great fit with the experience that we have developed over the past few years working with fusion proteins," said Robert J. Broeze, Ph. D., President & CEO of Laureate Pharma. "We have had great success working with these unique protein products and are delighted to have the opportunity to help advance this product into the clinic."

"We are seeing a strong trend in the biopharmaceutical industry to develop fusion protein products with unique properties," commented Dan Leone, Vice President, Business Development of Laureate Pharma. "Along with monoclonal antibodies, manufacturing fusion proteins has become one of Laureate's core competencies."

About Laureate Pharma

Laureate Pharma is a full-service biopharmaceutical development and protein production company located in Princeton, NJ. Laureate Pharma offers superior bioprocessing services that accelerate new products from development through production. Laureate provides a wide range of specialized services from process design and development to full-scale cGMP production, purification, aseptic filling, testing, validation, analytical services, and regulatory support. Laureate is focused on two active segments of the biopharmaceutical industry: monoclonal antibodies and recombina
'/>"/>

SOURCE Laureate Pharma, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Nobel Laureate Dr. Gunter Blobel to Speak at Florida Atlantic University
2. Peregrine Pharmaceuticals Reports 61% Objective Response Rate in 46-Patient Bavituximab Phase II Trial in Advanced Breast Cancer
3. NASCSA Receives $200,000 Grant From Purdue Pharma L.P. to Support State Prescription Drug Monitoring Programs
4. Cadence Pharmaceuticals CEO Ted Schroeder to Present at the BIOCOM Investor Conference in San Diego on October 27, 2009
5. Amylin Pharmaceuticals Reports Third Quarter Financial Results
6. Anadys Pharmaceuticals to Present at Two Upcoming Investor Conferences
7. Oramed Pharmaceuticals was Chosen to Present Results of a GLP-1 Analog Oral Administration Study at the Diabetes Technology Societys Ninth Annual Meeting (November 5-7, 2009; San Francisco, CA)
8. ISTA Pharmaceuticals to Present at 2009 BIOCOM Investor Conference
9. University Medical Pharmaceuticals Selects Jeffrey Ten as Senior Vice President, International Sales
10. Simcere Pharmaceutical Group Announces Collaboration with OSI Pharmaceuticals
11. Four Pharmaceutical Companies Pay $124 Million for Submission of False Claims to Medicaid

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)... , SCHAUMBERG, Ill., Nov. 19 ...ble, PACS-neutral healthcare image management solu...ment to provide a combined PACS- neutral archive s...er, Data Distributing, an international leader in ... solutions to the medical industry. Under the agr...
(Date:11/19/2009)... , PRINCETON, N.J., Nov. 19 ...g alternatives to traditional spinal fusion surger... its executive management team as the Vice Preside...go: http://www.newscom.com/cgi-bin/prnh/2008052...of clinical and regulatory experience in the spina...
(Date:11/19/2009)... , Primary Care Doctors, Endocrinologists F...ary Team Care ,, PRINCETON, N.J., Nov. 19 /PRN...aid they did not have enough time and did not rece...ive care to their patients with diabetes, accordin...d primary care doctors published today in America...
Breaking Medicine Technology:Mach 7 Technologies and QStar Sign Agreement to Deliver PACS-Neutral Solutions Through Mutual Channel Partner, Data Distributing 2Mach 7 Technologies and QStar Sign Agreement to Deliver PACS-Neutral Solutions Through Mutual Channel Partner, Data Distributing 3Mach 7 Technologies and QStar Sign Agreement to Deliver PACS-Neutral Solutions Through Mutual Channel Partner, Data Distributing 4Impliant Announces the Addition of Vice President of Clinical and Regulatory Affairs to Executive Management Team 2Impliant Announces the Addition of Vice President of Clinical and Regulatory Affairs to Executive Management Team 3Doctors Cite Time, Low Reimbursement As Barriers To Providing Comprehensive Diabetes Care, Survey Results Show 2Doctors Cite Time, Low Reimbursement As Barriers To Providing Comprehensive Diabetes Care, Survey Results Show 3Doctors Cite Time, Low Reimbursement As Barriers To Providing Comprehensive Diabetes Care, Survey Results Show 4Doctors Cite Time, Low Reimbursement As Barriers To Providing Comprehensive Diabetes Care, Survey Results Show 5Sparta Systems Launches Hong Kong Operations to Drive Enterprise Quality and Compliance in Asia Pacific Region 47503 1Sparta Systems Launches Hong Kong Operations to Drive Enterprise Quality and Compliance in Asia Pacific Region 47503 2Sparta Systems Launches Hong Kong Operations to Drive Enterprise Quality and Compliance in Asia Pacific Region 47503 3Exclusive Marketplace for Nursing Professionals Launched by Nurses Service Organization 47502 1Exclusive Marketplace for Nursing Professionals Launched by Nurses Service Organization 47502 2Exclusive Marketplace for Nursing Professionals Launched by Nurses Service Organization 47502 3Findings in Epilepsy Gene in Animals May Guide Treatment Directions for Infants 47500 1Findings in Epilepsy Gene in Animals May Guide Treatment Directions for Infants 47500 2Findings in Epilepsy Gene in Animals May Guide Treatment Directions for Infants 47500 3Findings in Epilepsy Gene in Animals May Guide Treatment Directions for Infants 47500 4
(Date:11/21/2009)...-- Milvia Lopez, by her attorney MICHAEL STEWART F...Supreme Court, New York County, bearing Index # 11...pez underwent a routine transesophageal echocardio...used an HIV infected scope exposing her to HIV. ...er being discharged from the procedure and arrivin...
(Date:11/21/2009)...credentialing software company IntelliSoft Group i...with Amerinet, Inc., the leading healthcare G.P.O....orm quality care within the healthcare market. , ...-- ISG Group, LLC, doing business as IntelliSoft G...Inc., a leading national healthcare group purchasi...
(Date:11/21/2009)...Group merges their practice with that of E. Steven... (PRWEB) November 21, 2009 -- The New Hav...ibson, Dr. Dean Cloutier, Dr. John Plachtyna and D...practice with that of esteemed colleague Dr. E. St...ed to retire from dentistry in order to concentrat...
(Date:11/20/2009)...e-USNewswire/ -- The American Academy of Actuarie...rm legislation released this week to contain stron...al coverage mandate. The actuaries said that an ef...rse selection stemming from more restrictive issue...he individual mandate language should be strengthe...
(Date:11/20/2009)...swire-FirstCall/ -- Rates of infection by the 2009...ber, but the pandemic flu virus continues to be a ...luding the elderly, according to a new report by Q...world,s leading provider of diagnostic testing, in...Quest Diagnostics Health Trends(TM) Report "Testin...
Breaking Medicine News(10 mins):Health News:Patient Files Suit Against St. Vincent's Hospital in New York City as a Result of the Alleged Use by the Hospital of an HIV Infected Device During a Routine Procedure 2Health News:IntelliSoft Group and Amerinet Inc. Form Partnership to Transform Healthcare Delivery of Quality Patient Safety and Care 2Health News:New Haven Dental Group Expands Their Vision 2Health News:Actuaries to Senate: Strengthen Individual Mandate 2Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 2Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 3
... Wyndgate Partner to Provide Solution to Teaching ...ulation Center, DENVER, June 10 Global Med Techn...ernational e-Health, medical,information technolog...ftware to Riverside County Regional Medical,Center...
...E, Fla., June 10 Blue Cross and Blue Shield,of Fl...tisfaction Among,Commercial Health Plans in Florid...J.D. Power and Associates 2008 National Health Ins...LOGOB ), BCBSF received the highest numerical sc...
...from an Expert in Making Fatherhood Happen, ATLAN...tics data indicate that Georgia had 149,919 new ba...vailable. That means, obviously, not only,were the... said,fertility expert Dr. Mark Perloe of Georgia ...
...UK: Researchers are harnessing the powers of digi... patients at home manage the side-effects caused b...and young adults specially adapted mobile phones o...ing basic advice about the most common symptoms, a...
...nd Brain Institute (QBI) neuroscientists at UQ hav...the brain of a person with Alzheimer,s disease. ,...an be attributed to several factors. , These inc...tion of a specific population of nerve cells in th...
...K, Ill. (June 10, 2008) Screening for lung cancer...g cancer deaths in current and former smokers, but...associated with smoking, according to a new study ...," said the study,s lead author, Pamela McMahon, P...
Other Medicine News:Health News:Global Med Technologies(R) Signs Agreement With California's Century Old Riverside County Regional Medical Center 2Health News:Global Med Technologies(R) Signs Agreement With California's Century Old Riverside County Regional Medical Center 3Health News:Blue Cross and Blue Shield of Florida Awarded Prestigious J.D. Power and Associates Award for Second Year 2Health News:Thinking About Being a Father? 2Health News:Managing symptoms by mobile phone may revolutionize cancer care for young people 2Health News:Managing symptoms by mobile phone may revolutionize cancer care for young people 3Health News:QBI neuroscientists make Alzheimer's disease advance 2Health News:CT lung cancer screening no cure-all for smokers 2
...atory and a worldwide leader in innovative laborat...sive test menu of highly complex and unique medica...by the University of Utah, ARUP Laboratories' clie...ity teaching hospitals and children's hospitals, m...
...atory and a worldwide leader in innovative laborat...sive test menu of highly complex and unique medica...by the University of Utah, ARUP Laboratories' clie...ity teaching hospitals and children's hospitals, m...
...atory and a worldwide leader in innovative laborat...sive test menu of highly complex and unique medica...by the University of Utah, ARUP Laboratories' clie...ity teaching hospitals and children's hospitals, m...
...atory and a worldwide leader in innovative laborat...sive test menu of highly complex and unique medica...by the University of Utah, ARUP Laboratories' clie...ity teaching hospitals and children's hospitals, m...
Medicine Products: